Metabolon Acquires Cogenics Icoria’s Issued and Pending Metabolomics IP | GenomeWeb
NEW YORK (GenomeWeb News) ― Metabolon said yesterday it has acquired metabolomics-related intellectual property from Cogenics Icoria, a Clinical Data subsidiary, for an undisclosed sum.
 
Research Triangle Park, NC-based Metabolon said it now possesses all of the metabolomics-related IP that Cogenics Icoria previously owned.
 
Clinical Data acquired Cogenics Icoria in 2005.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.